Literature DB >> 26448967

Brevetoxin Depuration in Shellfish via Production of Non-toxic Metabolites: Consequences for Seafood Safety and the Environmental Fate of Biotoxins.

J Naar1, J Kubanek2, A Weidner, L Flewelling, A Bourdelais, K Steidinger, D G Baden.   

Abstract

During blooms of the dinoflagellate Karenia brevis, filter-feeders such as oysters and clams bioaccumulate brevetoxins, often to levels that are toxic to humans. In controlled aquarium experiments, we exposed live oysters to bloom levels of toxic K. brevis, followed by 10 weeks of exposure to non-toxic microalgae. Oysters were harvested weekly and analyzed for brevetoxins and brevetoxin metabolites to quantify toxin bioaccumulation and depuration. All of the PbTx-2 concentrated by oysters was immediately converted to a mixture of polar metabolites that were then slowly eliminated from the oysters. However, 90% of measured PbTx-3 was eliminated within two weeks of toxic exposure but without apparent biotransformation. Extracts of oysters containing high levels of PbTx-3 were toxic to mice by intraperitoneal (IP) injection. Extracts of oysters harvested after PbTx-3 had been eliminated were non-toxic despite high concentrations of PbTx-2 metabolites. Oysters collected in Florida during and after a bloom of K. brevis contained polar metabolites of PbTx-2 as well as PbTx-3, but no PbTx-2. Again, PbTx-3 concentration was a good predictor of mouse toxicity. One hundred percent conversion of PbTx-2 to polar metabolites was also accomplished in vitro by spiking oyster or clam homogenate with PbTx-2, followed by a brief incubation at room temperature. These PbTx-2 metabolites did not kill mice, either orally or by intraperitoneal injection, even at concentrations 30 times greater than toxic PbTx-3 levels.

Entities:  

Year:  2004        PMID: 26448967      PMCID: PMC4593612     

Source DB:  PubMed          Journal:  Harmful Algae 2002 (2002)


  4 in total

1.  Monitoring brevetoxins during a Gymnodinium breve red tide: comparison of sodium channel specific cytotoxicity assay and mouse bioassay for determination of neurotoxic shellfish toxins in shellfish extracts.

Authors:  R Dickey; E Jester; R Granade; D Mowdy; C Moncreiff; D Rebarchik; M Robl; S Musser; M Poli
Journal:  Nat Toxins       Date:  1999

2.  Neurotoxic shellfish poisoning and brevetoxin metabolites: a case study from Florida.

Authors:  M A Poli; S M Musser; R W Dickey; P P Eilers; S Hall
Journal:  Toxicon       Date:  2000-07       Impact factor: 3.033

3.  Development of rapid and sensitive high throughput pharmacologic assays for marine phycotoxins.

Authors:  F M Van Dolah; E L Finley; B L Haynes; G J Doucette; P D Moeller; J S Ramsdell
Journal:  Nat Toxins       Date:  1994

4.  A competitive ELISA to detect brevetoxins from Karenia brevis (formerly Gymnodinium breve) in seawater, shellfish, and mammalian body fluid.

Authors:  Jerome Naar; Andrea Bourdelais; Carmelo Tomas; Julia Kubanek; Philip L Whitney; Leanne Flewelling; Karen Steidinger; Johnny Lancaster; Daniel G Baden
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

  4 in total
  3 in total

1.  Brevetoxins, like ciguatoxins, are potent ichthyotoxic neurotoxins that accumulate in fish.

Authors:  Jerome P Naar; Leanne J Flewelling; Allison Lenzi; Jay P Abbott; April Granholm; Henry M Jacocks; Damon Gannon; Michael Henry; Richard Pierce; Daniel G Baden; Jennifer Wolny; Jan H Landsberg
Journal:  Toxicon       Date:  2007-06-26       Impact factor: 3.033

Review 2.  Chemodiversity of Brevetoxins and Other Potentially Toxic Metabolites Produced by Karenia spp. and Their Metabolic Products in Marine Organisms.

Authors:  Vincent Hort; Eric Abadie; Nathalie Arnich; Marie-Yasmine Dechraoui Bottein; Zouher Amzil
Journal:  Mar Drugs       Date:  2021-11-24       Impact factor: 5.118

3.  Guidance Level for Brevetoxins in French Shellfish.

Authors:  Nathalie Arnich; Eric Abadie; Zouher Amzil; Marie-Yasmine Dechraoui Bottein; Katia Comte; Estelle Chaix; Nicolas Delcourt; Vincent Hort; César Mattei; Jordi Molgó; Raphaele Le Garrec
Journal:  Mar Drugs       Date:  2021-09-15       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.